News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current BXN market cap is 9.51M. The company's latest EPS is AUD -0.0010 and P/E is 0.00.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.2M | 2.33M | 2.2M | 2.48M | 5.31M |
| Operating Income | -1.4M | -651k | -255k | -139k | -2M |
| Net Income | -1.27M | -593k | -496k | -237k | -1.94M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.97M | 3.34M | 2.68M | 2.92M | 17.69M |
| Total Liabilities | 829k | 726k | 745k | 982k | 2.69M |
| Total Equity | 3.14M | 2.61M | 1.93M | 1.94M | 15.01M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.39M | 49k | 53k | 435k | -841k |
| Investing | -173k | -33k | N/A | -6k | 3.96M |
| Financing | N/A | -52k | -47k | N/A | 947k |
| Market Cap | 9.51M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 1.9B |
| Average Volume (1 week) | 1.76M |
| Average Volume (1 Month) | 1.2M |
| 52 Week Change | -79.17% |
| 52 Week High | 0.025 |
| 52 Week Low | 0.005 |
| Spread (Intraday) | 0 (20%) |
| Company Name | Bioxyne Ltd |
| Address |
suite 506, level 5 sydney, new south wales 2000 |
| Website | https://www.bioxyne.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
